Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2024

Have we seen everything from checkpoints inhibitors?

What do translational analytics teach us about IO therapy in solid tumours

Date

08 Dec 2024

Session

Have we seen everything from checkpoints inhibitors?

Topics

Clinical Research;  Cancer Biology;  Tumour Immunology;  Translational Research;  Cell-Based Therapy;  Immunotherapy

Tumour Site

Presenters

Kai-Keen Shiu

Authors

K. Shiu

Author affiliations

  • Oncology Dept., University College London Hospitals NHS Foundation Trust, NW1 2BU - London/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.